{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:46:31Z","timestamp":1792802791234,"version":"4.5.0"},"reference-count":321,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T00:00:00Z","timestamp":1665014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Casein kinases are involved in a variety of signaling pathways, and also in inflammation, cancer, and neurological diseases. Therefore, they are regarded as potential therapeutic targets for drug design. Recent studies have highlighted the importance of the casein kinase 1 superfamily as well as protein kinase CK2 in the development of several neurodegenerative pathologies, such as Alzheimer\u2019s disease, Parkinson\u2019s disease, Huntington\u2019s disease, and amyotrophic lateral sclerosis. CK1 kinases and their closely related tau tubulin kinases as well as CK2 are found to be overexpressed in the mammalian brain. Numerous substrates have been detected which play crucial roles in neuronal and synaptic network functions and activities. The development of new substances for the treatment of these pathologies is in high demand. The impact of these kinases in the progress of neurodegenerative disorders, their bona fide substrates, and numerous natural and synthetic compounds which are able to inhibit CK1, TTBK, and CK2 are discussed in this review.<\/jats:p>","DOI":"10.3389\/fmolb.2022.916063","type":"journal-article","created":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T13:18:20Z","timestamp":1665062300000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders"],"prefix":"10.3389","volume":"9","author":[{"given":"Andrea","family":"Baier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryszard","family":"Szyszka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11010-005-3076-2","article-title":"The catalytic subunit \u03b1\u2032 gene of human protein kinase CK2 (CSNK2A2): Genomic organization, promoter identification and determination of Ets1 as a key regulator","volume":"274","author":"Ackermann","year":"2005","journal-title":"Mol. Cell. Biochem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1021\/acs.jproteome.9b00312","article-title":"Therapeutic targeting of casein kinase 1\u03b4\/\u03b5 in an Alzheimer\u2019s disease mouse model","volume":"18","author":"Adler","year":"2019","journal-title":"J. Proteome Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1007\/s12035-016-9839-9","article-title":"Resveratrol and Alzheimer\u2019s disease: Mechanistic insights","volume":"54","author":"Ahmed","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.2174\/1871527320666210218084444","article-title":"Prospective role of polyphenolic compounds in the treatment of neurodegenerative diseases","volume":"20","author":"Akter","year":"2021","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"B5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13024-016-0102-7","article-title":"Targeting TDP-43 phosphorylation by casein kinase-1\u03b4 inhibitors: A novel strategy for the treatment of frontotemporal dementia","volume":"11","author":"Alquezar","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"B6","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nat. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","article-title":"The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)","volume":"40","author":"Ardito","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/ana.410430321","article-title":"Complex I defect in muscle from patients with Huntington\u2019s disease","volume":"43","author":"Arenas","year":"1998","journal-title":"Ann. Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nchembio.582","article-title":"Kinase inhibitors modulate huntingtin cell localization and toxicity","volume":"7","author":"Atwal","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s004010100423","article-title":"Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer\u2019s disease","volume":"103","author":"Augustinack","year":"2002","journal-title":"Acta Neuropathol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"12842","DOI":"10.1074\/jbc.M608243200","article-title":"Phosphorylation of parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation","volume":"282","author":"Avraham","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1242\/jcs.038950","article-title":"Structural determinants of the cellular localization and shuttling of TDP-43","volume":"121","author":"Ayala","year":"2008","journal-title":"J. Cell Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1021\/acs.jmedchem.1c00963","article-title":"Small molecule kinase inhibitor drugs (1995\u20132021): Medical indication, pharmacology, and synthesis","volume":"65","author":"Ayala-Aguilera","year":"2022","journal-title":"J. Med. Chem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1212\/01.wnl.0000334276.09729.0e","article-title":"Weight loss in Huntington disease increases with higher CAG repeat number","volume":"71","author":"Aziz","year":"2008","journal-title":"Neurology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1124\/jpet.107.122846","article-title":"An inhibitor of casein kinase I induces phase delays in circadian rhythms under free-running and entrained conditions","volume":"322","author":"Badura","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.phytochem.2016.12.018","article-title":"Selected flavonoid compounds as promising inhibitors of protein kinase CK2\u03b1 and CK2\u03b1\u2019, the catalytic subunits of CK2","volume":"136","author":"Baier","year":"2017","journal-title":"Phytochemistry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11010-017-3228-1","article-title":"Inhibitory influence of natural flavonoids on human protein kinase CK2 isoforms: Effect of the regulatory subunit","volume":"444","author":"Baier","year":"2018","journal-title":"Mol. Cell. Biochem."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3390\/biom10111546","article-title":"Compounds from natural sources as protein kinase inhibitors","volume":"10","author":"Baier","year":"2020","journal-title":"Biomolecules"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/md13031105","article-title":"Anticancer properties of lamellarins","volume":"13","author":"Bailly","year":"2015","journal-title":"Mar. Drugs"},{"key":"B21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/BJ20070797","article-title":"The selectivity of protein kinase inhibitors: A further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1182\/blood-2020-142557","article-title":"Trial in progress: A phase I trial of BTX-A51 in patients with relapsed or refractory aml or high-risk mds","volume":"136","author":"Ball","year":"2020","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.brainres.2017.02.021","article-title":"Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson\u2019s disease: Possible involvement of ER\u03b2\/Nrf2\/HO-1 signaling","volume":"1662","author":"Baluchnejadmojarad","year":"2017","journal-title":"Brain Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s10571-020-00875-6","article-title":"Mechanisms of regulation and diverse activities of tau-tubulin kinase (TTBK) isoforms","volume":"41","author":"Bao","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1523\/jneurosci.4988-09.2010","article-title":"Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis","volume":"30","author":"Barmada","year":"2010","journal-title":"J. Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/md20080026","article-title":"Anticancer alkaloid lamellarins inhibit protein kinases","volume":"6","author":"Baunb\u00e6k","year":"2008","journal-title":"Mar. Drugs"},{"key":"B27","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3389\/fnagi.2020.00242","article-title":"Clinically precedented protein kinases: Rationale for their use in neurodegenerative disease","volume":"12","author":"Benn","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1016\/j.bmcl.2013.05.075","article-title":"Development of highly selective casein kinase 1\u03b4\/1\u03b5 (CK1\u03b4\/\u03b5) inhibitors with potent antiproliferative properties","volume":"23","author":"Bibian","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B29","doi-asserted-by":"publisher","first-page":"7418","DOI":"10.1523\/JNEUROSCI.4540-06.2007","article-title":"Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: In vivo evidence","volume":"27","author":"Bichelmeier","year":"2007","journal-title":"J. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1083\/jcb.101.4.1371","article-title":"The distribution of tau in the mammalian central nervous system","volume":"101","author":"Binder","year":"1985","journal-title":"J. Cell Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1016\/S0021-9258(19)42622-7","article-title":"Casein kinase from the Golgi apparatus of lactating mam mary gland","volume":"249","author":"Bingham","year":"1974","journal-title":"J. Biol. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00726-012-1234-x","article-title":"2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent ihnhibitors CK1\u03b4\/\u03b5","volume":"43","author":"Bischof","year":"2012","journal-title":"Amino Acids"},{"key":"B33","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/s0301-0082(99)00026-x","article-title":"Casein kinase 2 as a potentially important enzyme in the nervous system","volume":"60","author":"Blanquet","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"113217","DOI":"10.1016\/j.ejmech.2021.113217","article-title":"Comparing the efficacy and selectivity of CK2 inhibitors. A phosphoproteomics approach","volume":"214","author":"Borgo","year":"","journal-title":"Eur. J. Med. Chem."},{"key":"B35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41392-021-00567-7","article-title":"Protein kinase CK2: A potential therapeutic target for diverse human diseases","volume":"6","author":"Borgo","year":"","journal-title":"Signal Transduct. Target. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1042\/bj20110276","article-title":"TTBK2 kinase substrate specificity and the impact of spinocerebellar-ataxia-causing mutations on expression, activity, localization and development","volume":"437","author":"Bouskila","year":"2011","journal-title":"Biochem. J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e51166","DOI":"10.7554\/eLife.51166","article-title":"TTBK2 and primary cilia are essential for the connectivity and survival of cerebellar Purkinje neurons","volume":"9","author":"Bowie","year":"2020","journal-title":"Elife"},{"key":"B39","doi-asserted-by":"publisher","first-page":"702788","DOI":"10.3389\/fnins.2021.702788","article-title":"Human tau isoforms and proteolysis for production of toxic tau fragments in neurodegeneration","volume":"15","author":"Boyarko","year":"2021","journal-title":"Front. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/acn3.755","article-title":"Alternative splicing in a presenilin 2 variant associated with Alzheimer disease","volume":"6","author":"Braggin","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.18632\/oncotarget.6361","article-title":"Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: Turning off the prosurvival ER chaperone BIP\/Grp78 and turning on the pro-apoptotic NF-\u03baB","volume":"7","author":"Buontempo","year":"2016","journal-title":"Oncotarget"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.1093\/hmg\/ddg344","article-title":"The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity","volume":"12","author":"Burnett","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"B44","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S0021-9258(18)71184-8","article-title":"The enzymatic phosphorylation of proteins","volume":"211","author":"Burnett","year":"1954","journal-title":"J. Biol. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"a024091","DOI":"10.1101\/cshperspect.a024091","article-title":"Cell biology and pathophysiology of \u03b1-synuclein","volume":"8","author":"Burr\u00e9","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/s1470-2045(18)30082-2","article-title":"Umbralisib, a novel PI3K\u03b4 and casein kinase-1\u03b5 inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: An open-label, phase 1, dose-escalation, first-in-human study","volume":"19","author":"Burris","year":"2018","journal-title":"Lancet. Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/jcb.10263","article-title":"Biochemical and cellular characteristics of the four splice variants of protein kinase CK1alpha from zebrafish (Danio rerio)","volume":"86","author":"Burzio","year":"2002","journal-title":"J. Cell. Biochem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s12975-015-0440-8","article-title":"Co-Ultramicronized palmitoylethanolamide\/luteolin in the treatment of cerebral ischemia: From rodent to man","volume":"7","author":"Caltagirone","year":"2015","journal-title":"Transl. Stroke Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"644747","DOI":"10.3389\/fmolb.2021.644747","article-title":"The molecular clock and neurodegenerative disease: A stressful time","volume":"8","author":"Carter","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ph10010007","article-title":"CK2\u2014an emerging target for neurological and psychiatric disorders","volume":"10","author":"Castello","year":"2017","journal-title":"Pharmaceuticals"},{"key":"B51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13062-017-0176-3","article-title":"Post translational modification of Parkin","volume":"12","author":"Chakraborty","year":"2017","journal-title":"Biol. Direct"},{"key":"B52","doi-asserted-by":"publisher","first-page":"13478","DOI":"10.1038\/s41598-017-13791-5","article-title":"Up-regulation of casein kinase 1\u03b5 is involved in tau pathogenesis in Alzheimer\u2019s disease","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: Structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1038\/onc.2010.627","article-title":"IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1\u03b4\/\u025b and Wnt\/\u03b2-catenin independent inhibition of mitotic spindle formation","volume":"30","author":"Cheong","year":"2011","journal-title":"Oncogene"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1016\/j.febslet.2006.06.021","article-title":"Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine","volume":"580","author":"Chohan","year":"2006","journal-title":"FEBS Lett."},{"key":"B56","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fphar.2015.00070","article-title":"The casein kinase 2 inhibitor, CX-4945, as an anti-cancer drug in treatment of human hematological malignancies","volume":"6","author":"Chon","year":"2015","journal-title":"Front. Pharmacol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"13170","DOI":"10.1073\/pnas.93.23.13170","article-title":"Evidence that the 42- and 40-amino acid forms of amyloid \u03b2 protein are generated from the \u03b2-amyloid precursor protein by different protease activities","volume":"93","author":"Citron","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B58","doi-asserted-by":"publisher","first-page":"E127","DOI":"10.1038\/ncb0502-e127","article-title":"The origins of protein phosphorylation","volume":"4","author":"Cohen","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/hmg\/ddg328","article-title":"RING finger 1 mutations in parkin produce altered localization of the protein","volume":"12","author":"Cookson","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"B61","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/ng1503","article-title":"Polyglutamine expansion of huntingtin impairs its nuclear export","volume":"37","author":"Cornett","year":"2005","journal-title":"Nat. Genet."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/016355581.2021.1977834","article-title":"Pro-oxidant efeect of resveratrol on human breast cancer MCF-7 cells is associated with CK2 inhibition","volume":"14","author":"Costa","year":"2021","journal-title":"Nutr. Cancer"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1021\/jm060112m","article-title":"Identification of ellagic acid as potent inhibitor of protein kinase CK2: A successful example of a virtual screening application","volume":"49","author":"Cozza","year":"2006","journal-title":"J. Med. Chem."},{"key":"B64","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.1016\/j.bmcl.2008.08.072","article-title":"Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening","volume":"18","author":"Cozza","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B65","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1042\/bj20090069","article-title":"Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2","volume":"421","author":"Cozza","year":"2009","journal-title":"Biochem. J."},{"key":"B66","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1517\/14728222.2016.1091883","article-title":"Casein kinases as potential therapeutic targets","volume":"20","author":"Cozza","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1517\/13543776.2012.717615","article-title":"Protein kinase CK2 inhibitors: A patent review","volume":"22","author":"Cozza","year":"2012","journal-title":"Expert Opin. Ther. Pat."},{"key":"B68","doi-asserted-by":"publisher","first-page":"734127","DOI":"10.1155\/2015\/734127","article-title":"The selectivity of CK2 inhibitor quinalizarin: A reevaluation","volume":"2015","author":"Cozza","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"B69","doi-asserted-by":"publisher","first-page":"29983","DOI":"10.1038\/srep29983","article-title":"Targeting of the circadian clock via CK1\u03b4\/\u03b5 to improve glucose homeostasis in obesity","volume":"6","author":"Cunningham","year":"2016","journal-title":"Sci. Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/biof.1703","article-title":"Protection against Alzheimer's disease by luteolin: Role of brain glucose regulation, anti-inflammatory activity, and the gut microbiota-liver-brain axis","volume":"47","author":"Daily","year":"2021","journal-title":"Biofactors"},{"key":"B71","doi-asserted-by":"publisher","first-page":"112267","DOI":"10.1016\/j.ejmech.2020.112267","article-title":"A novel class of selective CK2 inhibitors targeting its open hinge conformation","volume":"195","author":"Dalle Vedove","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"B72","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.1007\/s12035-018-1449-2","article-title":"Inhibition of LRRK2 or casein kinase 1 results in LRRK2 protein destabilization","volume":"56","author":"De Wit","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"39626","DOI":"10.1074\/jbc.M112.412379","article-title":"Identification of a karyopherin \u03b21\/\u03b22 proline-tyrosine nuclear localization signal in huntingtin protein","volume":"287","author":"Desmond","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/glia.20153","article-title":"Retinoic acid inhibits expression of TNF-\u03b1 and iNOS in activated rat microglia","volume":"50","author":"Dheen","year":"2005","journal-title":"Glia"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e0228771","DOI":"10.1371\/journal.pone.0228771","article-title":"Acute inhibition of the CNS-specific kinase TTBK1 significantly lowers tau phosphorylation at several disease relevant sites","volume":"15","author":"Dillon","year":"2020","journal-title":"PLOS ONE"},{"key":"B76","doi-asserted-by":"publisher","first-page":"947","DOI":"10.18388\/abp.2005_3413","article-title":"Different properties of four molecular forms of protein kinase CK2 from Saccharomyces cerevisiae","volume":"52","author":"Doma\u0144ska","year":"2005","journal-title":"Acta Biochim. Pol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e1004049","DOI":"10.1371\/journal.pcbi.1004049","article-title":"The roles of post-translational modifications in the context of protein interaction networks","volume":"11","author":"Duan","year":"2015","journal-title":"PLoS Comput. Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s40199-019-00309-9","article-title":"Ellagic acid reduces methotrexate-induced apoptosis and mitochondrial dysfunction via up-regulating Nrf2 expression and inhibiting the I\u0138B\u03b1\/NF\u0138B in rats","volume":"27","author":"Ebrahimi","year":"2019","journal-title":"DARU"},{"key":"B79","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/s0014-5793(98)01419-7","article-title":"Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of \u03b1-synuclein protein implicated in Parkinson\u2019s disease","volume":"440","author":"El-Agnaf","year":"1998","journal-title":"FEBS Lett."},{"key":"B80","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1074\/jbc.M010316200","article-title":"alpha-synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases","volume":"276","author":"Ellis","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B81","doi-asserted-by":"publisher","first-page":"11474","DOI":"10.1523\/JNEUROSCI.2053-06.2006","article-title":"Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation","volume":"26","author":"Evert","year":"2006","journal-title":"J. Neurosci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1097\/00001756-200205070-00036","article-title":"Alternative transcripts of presenilin-1 associated with frontotemporal dementia","volume":"13","author":"Evin","year":"2002","journal-title":"Neuroreport"},{"key":"B83","doi-asserted-by":"publisher","first-page":"110234","DOI":"10.1016\/j.biopha.2020.110234","article-title":"The therapeutic effect of resveratrol: Focusing on the Nrf2 signaling pathway","volume":"127","author":"Farkhondeh","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B84","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1073\/pnas.0611236104","article-title":"Regulation of Alzheimer\u2019s disease amyloid-beta formation by casein kinase I","volume":"104","author":"Flajolet","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B85","doi-asserted-by":"publisher","first-page":"3724","DOI":"10.1016\/S0021-9258(19)67854-3","article-title":"Role of acidic residues as substrate determinants for casein kinase I.","volume":"266","author":"Flotow","year":"1991","journal-title":"J. Biol. Chem."},{"key":"B86","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.bbapap.2014.09.017","article-title":"Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells","volume":"1854","author":"Franchin","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"B87","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","article-title":"Alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.alkal.2019.10.001","article-title":"Lamellarin alkaloids: Isolation, synthesis, and biological activity","volume":"83","author":"Fukuda","year":"2020","journal-title":"Alkaloids. Chem. Biol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1042\/BCJ20200506","article-title":"Functions and regulation of the serine\/threonine protein kinase CK1 family: Moving beyond promiscuity","volume":"477","author":"Fulcher","year":"2020","journal-title":"Biochem. J."},{"key":"B90","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/s0140-6736(05)79256-4","article-title":"Multiple-system atrophy: A new a-synuclein disease?","volume":"352","author":"Gai","year":"1998","journal-title":"Lancet"},{"key":"B91","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1021\/acs.jmedchem.8b00095","article-title":"Discovery of inhibitor of Wnt production 2 (IWP-2) and related compounds as selective ATP-competitive inhibitors of casein kinase 1 (CK1) \u03b4\/\u03b5","volume":"61","author":"Garc\u00eda-Reyes","year":"2018","journal-title":"J. Med. Chem."},{"key":"B92","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00439-016-1683-5","article-title":"The hnRNP family: Insights into their role in health and disease","volume":"135","author":"Geuens","year":"2016","journal-title":"Hum. Genet."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/s0002-9440(10)65219-4","article-title":"A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer\u2019s disease","volume":"155","author":"Ghoshal","year":"1999","journal-title":"Am. J. Pathol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/s0006-291x(84)80190-4","article-title":"Alzheimer\u2019s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B95","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.ejmech.2010.12.025","article-title":"Synthesis and biological evaluation of substituted (thieno[2, 3-d]pyrimidin-4-ylthio)carboxylic acids as inhibitors of human protein kinase CK2","volume":"46","author":"Golub","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"B96","doi-asserted-by":"publisher","first-page":"8152373","DOI":"10.1155\/2018\/8152373","article-title":"Neuroprotective mechanisms of resveratrol in Alzheimer\u2019s disease: Role of SIRT1","volume":"2018","author":"Gomes","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.2174\/092986708785909111","article-title":"Hyperphosphorylation of microtubule-associated protein tau: A promising therapeutic target for alzheimer disease","volume":"15","author":"Gong","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"B98","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1471-4159.1993.tb03603.x","article-title":"Phosphoprotein phosphatase activities in Alzheimer disease brain","volume":"61","author":"Gong","year":"1993","journal-title":"J. Neurochem."},{"key":"B99","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1016\/S0021-9258(17)41790-x","article-title":"Casein kinase II preferentially phosphorylates human tau isoforms containing an amino-terminal insert. Identification of threonine 39 as the primary phosphate acceptor","volume":"269","author":"Greenwood","year":"1994","journal-title":"J. Biol. Chem."},{"key":"B100","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B101","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3109\/13880209.2012.716852","article-title":"Neuroprotective effects of luteolin against apoptosis induced by 6-hydroxydopamine on rat pheochromocytoma PC12 cells","volume":"51","author":"Guo","year":"2013","journal-title":"Pharm. Biol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1083\/jcb.141.5.1097","article-title":"The influence of huntingtin protein size on nuclear localization and cellular toxicity","volume":"141","author":"Hackam","year":"1998","journal-title":"J. Cell Biol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3390\/molecules24071380","article-title":"In vitro and in silico evaluation of bikaverin as a potent inhibitor of human protein kinase CK2","volume":"24","author":"Haidar","year":"2019","journal-title":"Molecules"},{"key":"B104","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3390\/molecules22040522","article-title":"Optimized 4, 5-diarylimidazoles as potent\/selective inhibitors of protein kinase CK1\u03b4 and their structural relation to p38\u03b1 MAPK","volume":"22","author":"Halekotte","year":"2017","journal-title":"Molecules"},{"key":"B105","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.1021\/acs.jmedchem.1c00382","article-title":"Discovery of potent and brain-penetrant tau tubulin kinase 1 (TTBK1) inhibitors that lower tau phosphorylation in vivo","volume":"64","author":"Halkina","year":"2021","journal-title":"J. Med. Chem."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/hmg\/ddl131","article-title":"Biochemical analysis of Parkinson\u2019s disease-causing variants of parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity","volume":"15","author":"Hampe","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"B107","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","article-title":"Tau phosphorylation: The therapeutic challenge for neurodegenerative disease","volume":"15","author":"Hanger","year":"2009","journal-title":"Trends Mol. Med."},{"key":"B108","doi-asserted-by":"publisher","first-page":"23645","DOI":"10.1074\/jbcM703269200","article-title":"Novel phosphorylation sites in tau from alzheimer brain support a role for casein kinase 1 in disease pathogenesis","volume":"282","author":"Hanger","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B109","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1096\/fasebj.9.8.7768349","article-title":"The eukaryotic protein kinase superfamily: Kinase (catalytic) domain structure and classification 1","volume":"9","author":"Hanks","year":"1995","journal-title":"FASEB J."},{"key":"B110","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"1256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"B111","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/Ana.21425","article-title":"Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"64","author":"Hasegawa","year":"2008","journal-title":"Ann. Neurol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S0021-9258(17)37871-7","article-title":"Cyclic nucleotide-independent protein kinases from rabbit reticulocytes. Purification of casein kinases","volume":"254","author":"Hathaway","year":"1979","journal-title":"J. Biol. Chem."},{"key":"B113","doi-asserted-by":"publisher","first-page":"115","DOI":"10.29356\/jmcs.v63i4.729","article-title":"Cytotoxic and antitumoral effects of bikaverin from Gibberella fujikuroi on L5178Y lymphoma murine model","volume":"63","author":"Hinojosa-Ventura","year":"2019","journal-title":"J. Mex. Chem. Soc."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/ng.2007.43","article-title":"Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11","volume":"39","author":"Houlden","year":"2007","journal-title":"Nat. Genet."},{"key":"B115","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.1016\/j.bmcl.2012.07.046","article-title":"2-Phenylamino-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1\u03b3) inhibitors","volume":"22","author":"Hua","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B116","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0092-8674(95)90405-0","article-title":"Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling","volume":"80","author":"Hunter","year":"1995","journal-title":"Cell"},{"key":"B117","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1098\/rstb.2012.0013","article-title":"Why nature chose phosphate to modify proteins","volume":"367","author":"Hunter","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"B118","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fnmol.2014.00033","article-title":"Tau-tubulin kinase","volume":"7","author":"Ikezu","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"B119","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40478-020-0890-4","article-title":"Tau-tubulin kinase 1 and amyloid-\u03b2 peptide induce phosphorylation of collapsin response mediator protein-2 and enhance neurite degeneration in Alzheimer disease mouse models","volume":"8","author":"Ikezu","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"B120","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.febslet.2008.07.027","article-title":"Abnormal phosphorylation of ser409\/410 of TDP-43 in FTLD-U and ALS","volume":"582","author":"Inukai","year":"2008","journal-title":"FEBS Lett."},{"key":"B121","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1016\/j.febslet.2007.08.067","article-title":"Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: Implication for alpha-synucleinopathies","volume":"581","author":"Ishii","year":"2007","journal-title":"FEBS Lett."},{"key":"B122","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3987\/rev-10-686","article-title":"Synthesis and biological activity of lamellarin alkaloids: An overview","volume":"83","author":"Iwao","year":"2011","journal-title":"HETEROCYCLES"},{"key":"B123","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.cell.2012.10.027","article-title":"TTBK2 kinase: Linking primary cilia and cerebellar ataxias","volume":"151","author":"Jackson","year":"2012","journal-title":"Cell"},{"key":"B124","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1021\/bi00552a027","article-title":"Inhibition of microtubule assembly by phosphorylation of microtubule-associated proteins","volume":"19","author":"Jameson","year":"1980","journal-title":"Biochemistry"},{"key":"B125","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1080\/07391102.2019.1590242","article-title":"Identification of human tau-tubulin kinase 1inhibitors: An integrated e-pharmacophore based virtual screening and molecular dynamics simulation","volume":"38","author":"Jana","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"B126","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ejmech.2011.11.002","article-title":"CK2\u03b1 and CK2\u03b1\u2032 subunits differ in their sensitivity to 4, 5, 6, 7-tetrabromo- and 4, 5, 6, 7-tetraiodo-1H-benzimidazole derivatives","volume":"47","author":"Janeczko","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"B127","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1084\/jem.20131033","article-title":"Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia","volume":"211","author":"J\u00e4r\u00e5s","year":"2014","journal-title":"J. Exp. Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12964-018-0236-z","article-title":"Casein kinase 1\u03b1: Biological mechanisms and theranostic potential","volume":"16","author":"Jiang","year":"2018","journal-title":"Cell Commun. Signal."},{"key":"B129","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1098\/rstb.2012.0106","article-title":"Modular evolution of phosphorylation-based signalling systems","volume":"367","author":"Jin","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"B130","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.bbrc.2009.03.038","article-title":"Identification of casein kinase-1 phosphorylation sites on TDP-43","volume":"382","author":"Kametani","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1016\/j.bmcl.2004.02.003","article-title":"Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells","volume":"14","author":"Kang","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B132","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00401-006-0049-9","article-title":"Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions","volume":"111","author":"Kannanayakal","year":"2006","journal-title":"Acta Neuropathol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"207691","DOI":"10.4061\/2011\/207691","article-title":"Small changes huge impact: The role of protein posttranslational modifications in cellular homeostasis and disease","volume":"2011","author":"Karve","year":"2011","journal-title":"J. Amino Acids"},{"key":"B134","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1107\/S2053230X14000144","article-title":"The structure of human tau-tubulin kinase 1 both in the apo form and in complex with an inhibitor","volume":"70","author":"Kiefer","year":"2014","journal-title":"Acta Crystallogr. F. Struct. Biol. Commun."},{"key":"B135","doi-asserted-by":"publisher","first-page":"83","DOI":"10.18632\/aging.101361","article-title":"Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury","volume":"10","author":"Kim","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e94978","DOI":"10.1371\/journal.pone.0094978","article-title":"Identification of a novel function of CX-4945 as a splicing regulator","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"B137","doi-asserted-by":"publisher","first-page":"495","DOI":"10.17179\/excli2021-3492","article-title":"Flavonoids for treatment of Alzheimer\u2019s disease: An up todate review","volume":"20","author":"Kim","year":"2021","journal-title":"EXCLI J."},{"key":"B138","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.cellsig.2004.12.011","article-title":"The casein kinase 1 family: Participation in multiple cellular processes in eukaryotes","volume":"17","author":"Knippschild","year":"2005","journal-title":"Cell. Signal."},{"key":"B139","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.advms.2020.08.002","article-title":"Review of beneficial effects of resveratrol in neurodegenerative diseases such as Alzheimer\u2019s disease","volume":"65","author":"Komorowska","year":"2020","journal-title":"Adv. Med. Sci."},{"key":"B140","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1021\/cn5002254","article-title":"Efficient modification of alpha-synuclein serine 129 by protein kinase CK1 requires phosphorylation of tyrosine 125 as a priming event","volume":"5","author":"Kosten","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"B141","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1164\/ajrccm.165.6.2101049","article-title":"Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice","volume":"165","author":"Kotanidou","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B142","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-010-0658-1","article-title":"Protein coding of neurodegenerative dementias: The neuropathological basis of biomarker diagnostics","volume":"119","author":"Kovacs","year":"2010","journal-title":"Acta Neuropathol."},{"key":"B326","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1124\/mol.111.071126","article-title":"Resveratrol Restores Nrf2 Level and Prevents Ethanol-Induced Toxic Effects in the Cerebellum of a Rodent Model of Fetal Alcohol Spectrum Disorders","volume":"80","author":"Kumar","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.exger.2017.05.014","article-title":"Luteolin as a potential preventive and therapeutic candidate for Alzheimer\u2019s disease","volume":"95","author":"Kwon","year":"2017","journal-title":"Exp. Gerontol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nrn2168","article-title":"Intracellular amyloid-\u03b2 in Alzheimer\u2019s disease","volume":"8","author":"LaFerla","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"B146","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1432-1033.1997.00719.x","article-title":"Rat liver Golgi apparatus contains a protein kinase similar to the casein kinase of lactating mam mary gland","volume":"243","author":"Lasa","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"B147","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/ars.2015.6549","article-title":"Repurposing the NRF2 activator dimethyl fumarate as therapy against synucleinopathy in Parkinson\u2019s disease","volume":"25","author":"Lastres-Becker","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"B148","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00441-010-0960-1","article-title":"Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4, 5, 6, 7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro","volume":"340","author":"\u0141awnicka","year":"2010","journal-title":"Cell Tissue Res."},{"key":"B149","doi-asserted-by":"publisher","first-page":"10608","DOI":"10.1002\/anie.201103915","article-title":"A small molecule modulates circadian rhythms through phosphorylation of the period protein","volume":"50","author":"Lee","year":"2011","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"B150","doi-asserted-by":"publisher","first-page":"6125068","DOI":"10.1155\/2019\/6125068","article-title":"Structural basis for the selective inhibition of cdc2-like kinases by CX-4945","volume":"2019","author":"Lee","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"B152","first-page":"20","article-title":"Structure-activity relationship of 7 flavonoids on recombinant human protein kinase CK2 holoenzyme","volume":"34","author":"Li","year":"2009","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban."},{"key":"B153","doi-asserted-by":"publisher","first-page":"15938","DOI":"10.1074\/jbc.M314116200","article-title":"Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules","volume":"279","author":"Li","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B154","doi-asserted-by":"publisher","first-page":"e23075","DOI":"10.1371\/journal.pone.0023075","article-title":"Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation","volume":"6","author":"Li","year":"2011","journal-title":"PLoS One"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.bmcl.2013.01.012","article-title":"Inhibiting NF-\u03baB-inducing kinase (NIK): Discovery, structure-based design, synthesis, structure\u2013activity relationship, and co-crystal structures","volume":"23","author":"Li","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"B156","doi-asserted-by":"publisher","first-page":"6998","DOI":"10.1021\/bi960581y","article-title":"Molecular identification of I1PP2A, a novel potent heat-stable inhibitor protein of protein phosphatase 2A","volume":"35","author":"Li","year":"1996","journal-title":"Biochemistry"},{"key":"B157","doi-asserted-by":"publisher","first-page":"e1004803","DOI":"10.1371\/journal.pgen.1004803","article-title":"The tau tubulin kinases TTBK1\/2 promote accumulation of pathological TDP-43","volume":"10","author":"Liachko","year":"2014","journal-title":"PLoS Genet."},{"key":"B158","doi-asserted-by":"publisher","first-page":"575170","DOI":"10.1155\/2015\/575170","article-title":"TTBK2: A tau protein kinase beyond tau phosphorylation","volume":"2015","author":"Liao","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"B159","doi-asserted-by":"publisher","first-page":"5301","DOI":"10.1016\/S0021-9258(17)42989-9","article-title":"Phosphorylation affects the ability of tau protein to promote microtubule assembly","volume":"259","author":"Lindwall","year":"1984","journal-title":"J. Biol. Chem."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/s0002-9440(10)65722-7","article-title":"Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes","volume":"153","author":"Lippa","year":"1998","journal-title":"Am. J. Pathol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20021469","article-title":"Protein kinase CK2: Structure, regulation and role in cellular decisions of life and death","volume":"369","author":"Litchfield","year":"2003","journal-title":"Biochem. J."},{"key":"B162","doi-asserted-by":"publisher","first-page":"7395","DOI":"10.1111\/jcmm.16767","article-title":"Csnk1a1 inhibition modulates the inflammatory secretome and enhances response to radiotherapy in glioma","volume":"25","author":"Liu","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"B163","first-page":"1237","article-title":"Resveratrol attenuates spinal cord injury-induced inflammatory damage in rat lungs","volume":"8","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1139\/apnm-2016-0651","article-title":"Ellagic acid protects against neuron damage in ischemic stroke through regulating the ratio of Bcl-2\/Bax expression","volume":"42","author":"Liu","year":"2017","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"B165","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1021\/bi300531c","article-title":"Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight","volume":"51","author":"Lolli","year":"2012","journal-title":"Biochemistry"},{"key":"B166","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/138955709787001712","article-title":"Distribution and biological activities of the flavonoid luteolin","volume":"9","author":"Lopez-Lazaro","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"B167","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/bpa.12001","article-title":"Tau-tubulin kinase 1 expression, phosphorylation and Co-localization with phospho-ser422 tau in the Alzheimer\u2019s disease brain","volume":"23","author":"Lund","year":"2013","journal-title":"Brain Pathol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/s1097-2765(02)00602-0","article-title":"Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions","volume":"10","author":"Lunkes","year":"2002","journal-title":"Mol. Cell"},{"key":"B169","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S1474-4422(10)70195-2","article-title":"TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"9","author":"Mackenzie","year":"2010","journal-title":"Lancet. Neurol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/hmg\/ddq460","article-title":"ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington\u2019s disease","volume":"20","author":"Maher","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"B171","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3233\/JAD-2009-0986","article-title":"A novel Italian presenilin 2 gene mutation with prevalent behavioral phenotype","volume":"16","author":"Marcon","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"B172","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1432-1033.1994.tb19037.x","article-title":"Phosphorylation of synthetic fragments of inhibitor-2 of protein phosphatase-1 by casein kinase-1 and -2. Evidence that phosphorylated residues are not strictly required for efficient targeting by casein kinase-1","volume":"223","author":"Marin","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"B173","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: A neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"Maroteaux","year":"1988","journal-title":"J. Neurosci."},{"key":"B174","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1038\/s41598-020-61265-y","article-title":"Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1\u03b4 kinase inhibitor treatment","volume":"10","author":"Mart\u00ednez-Gonz\u00e1lez","year":"2020","journal-title":"Sci. Rep."},{"key":"B175","doi-asserted-by":"publisher","first-page":"20052","DOI":"10.1074\/jbcM001713200","article-title":"Crystal structure of a conformation-selective casein kinase-1 inhibitor","volume":"275","author":"Mashhoon","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B176","doi-asserted-by":"publisher","first-page":"9412","DOI":"10.1074\/jbc.m114.610774","article-title":"Parkinson disease mutant E46K enhances \u03b1-synuclein phosphorylation in mammalian cell lines, in yeast, and in vivo","volume":"290","author":"Mbefo","year":"2015","journal-title":"J. Biol. Chem."},{"key":"B177","first-page":"401","article-title":"Substrate specificity of protein kinase CK2","volume":"40","author":"Meggio","year":"1994","journal-title":"Cell. Mol. Biol. Res."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/0006-291x(92)91898-z","article-title":"The comparative efficiencies of the Ser(P)-Thr(P)- and Tyr(P)-residues as specificity determinants for casein kinase-1","volume":"182","author":"Meggio","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B179","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0014-5793(91)80614-9","article-title":"A synthetic \u03b2-casein phosphopeptide and analogues as model substrates for casein kinase-1, a ubiquitous, phosphate directed protein kinase","volume":"283","author":"Meggio","year":"1991","journal-title":"FEBS Lett."},{"key":"B180","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1096\/fj.02-0473rev","article-title":"One-thousand-and-one substrates of protein kinase CK2?","volume":"17","author":"Meggio","year":"2003","journal-title":"FASEB J."},{"key":"B181","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1432-1033.1997.t01-2-00527.x","article-title":"Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5","volume":"243","author":"Meijer","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"B182","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/s1074-5521(00)00063-6","article-title":"Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent.","volume":"7","author":"Meijer","year":"2000","journal-title":"Chem. Biol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"15240","DOI":"10.1073\/pnas.1005101107","article-title":"Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes","volume":"107","author":"Meng","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.neuroimage.2010.05.086","article-title":"Connectivity-based segmentation of the substantia nigra in human and its implications in Parkinson's disease","volume":"52","author":"Menke","year":"2010","journal-title":"Neuroimage"},{"key":"B186","doi-asserted-by":"publisher","first-page":"824956","DOI":"10.3389\/fnmol.2022.824956","article-title":"Evaluation of a selective chemical probe validates that CK2 mediates neuroinflammation in a human induced pluripotent stem cell-derived mircroglial model","volume":"15","author":"Mishra","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"B187","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1021\/acsomega.7b00869","article-title":"Biological and pharmacological characterization of benzothiazole-based CK-1\u03b4 inhibitors in models of Parkinson\u2019s disease","volume":"2","author":"Morales-Garcia","year":"2017","journal-title":"ACS Omega"},{"key":"B188","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1124\/mol.114.097345","article-title":"Identification of a dual inhibitor of SRPK1 and CK2 that attenuates pathological angiogenesis of macular degeneration in mice","volume":"88","author":"Morooka","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1093\/hmg\/ddp274","article-title":"CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3","volume":"18","author":"Mueller","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"B190","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/jad-2010-1221","article-title":"Alzheimer\u2019s disease and the amyloid-\u03b2 peptide","volume":"19","author":"Murphy","year":"2010","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B191","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.3390\/ijms20112761","article-title":"Quercetin regulates the integrated stress response to improve memory","volume":"20","author":"Nakagawa","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B192","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1006\/bbrc.2000.4253","article-title":"Activated Fyn phosphorylates alpha-synuclein at tyrosine residue 125","volume":"280","author":"Nakamura","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B193","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/s0955-0674(97)80016-6","article-title":"Nuclear export of proteins and RNAs","volume":"9","author":"Nakielny","year":"1997","journal-title":"Curr. Opin. Cell Biol."},{"key":"B194","doi-asserted-by":"publisher","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","article-title":"Both familial Parkinson\u2019s disease mutations accelerate alpha-synuclein aggregation","volume":"274","author":"Narhi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B195","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1096\/fj.01-0517fje","article-title":"Multiple phosphorylation of alpha-synuclein by protein tyrosine kinase Syk prevents eosin-induced aggregation","volume":"16","author":"Negro","year":"2002","journal-title":"FASEB J."},{"key":"B196","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1093\/brain\/awr201","article-title":"FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations","volume":"134","author":"Neumann","year":"2011","journal-title":"Brain"},{"key":"B197","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"B198","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s10571-014-0073-6","article-title":"Neuroprotective effects of bikaverin on H2O2-induced oxidative stress mediated neuronal damage in SH-SY5Y cell line","volume":"34","author":"Nirmaladevi","year":"2014","journal-title":"Cell. Mol. Neurobiol."},{"key":"B199","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3389\/fgene.2014.00270","article-title":"Physicochemical mechanisms of protein regulation by phosphorylation","volume":"5","author":"Nishi","year":"2014","journal-title":"Front. Genet."},{"key":"B200","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1074\/jbc.M115.695379","article-title":"Phosphorylation of TAR DNA-binding protein of 43 kDa (TDP-43) by truncated casein kinase 1 delta triggers mislocalization and accumulation of TDP-43","volume":"291","author":"Nonaka","year":"2016","journal-title":"J. Biol. Chem."},{"key":"B201","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejmech.2018.10.030","article-title":"Tau Tubulin Kinase 1 (TTBK1), a new player in the fight against neurodegenerative diseases","volume":"161","author":"Nozal","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"B202","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1021\/acs.jmedchem.1c01942","article-title":"TDP-43 modulation by tau-tubulin kinase 1 inhibitors: A new avenue for future amyotrophic lateral sclerosis therapy","volume":"65","author":"Nozal","year":"2022","journal-title":"J. Med. Chem."},{"key":"B203","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer\u2019s disease","volume":"34","author":"O\u2019Brien","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"key":"B204","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1074\/jbc.275.1.390","article-title":"Constitutive phosphorylation of the Parkinson\u2019s disease associated alpha-synuclein","volume":"275","author":"Okochi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B205","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3233\/jad-170176","article-title":"Protein phosphorylation is a key mechanism in Alzheimer\u2019s disease","volume":"58","author":"Oliveira","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"B206","doi-asserted-by":"publisher","first-page":"eaau9060","DOI":"10.1126\/sciadv.aau9060","article-title":"Cell-based screen identifies a new potent and highly selective CK2 inhibitor for modulation of circadian rhythms and cancer cell growth","volume":"5","author":"Oshima","year":"2019","journal-title":"Sci. Adv."},{"key":"B207","doi-asserted-by":"publisher","first-page":"3584","DOI":"10.1128\/JVI.69.6.3584-3596.1995","article-title":"Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs","volume":"69","author":"Ou","year":"1995","journal-title":"J. Virol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3233\/JPD-160779","article-title":"Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: What have we learned in the last decade?","volume":"6","author":"Oueslati","year":"2016","journal-title":"J. Park. Dis."},{"key":"B209","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1042\/bj20080309","article-title":"The selectivity of inhibitors of protein kinase CK2: An update","volume":"415","author":"Pagano","year":"2008","journal-title":"Biochem. J."},{"key":"B210","doi-asserted-by":"publisher","first-page":"16895","DOI":"10.1074\/jbc.m800747200","article-title":"Phosphorylation at ser-129 but not the phosphomimics S129E\/D inhibits the fibrillation of \u03b1-synuclein","volume":"283","author":"Paleologou","year":"2008","journal-title":"J. Biol. Chem."},{"key":"B211","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1111\/bph.15221","article-title":"Protein kinase inhibitors for amyotrophic lateral sclerosis therapy","volume":"178","author":"Palomo","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B212","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/med.20207","article-title":"Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases.","volume":"31","author":"Perez","year":"2011","journal-title":"Med. Res. Rev."},{"key":"B213","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11010-011-0956-5","article-title":"Pre-clinical characterization of CX-4945, a potent and selective small molecule inhibitor of CK2 for the treatment of cancer","volume":"356","author":"Pierre","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"B214","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1242\/jcs.00074","article-title":"Protein kinase CK2: A challenge to canons","volume":"115","author":"Pinna","year":"2002","journal-title":"J. Cell Sci."},{"key":"B215","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1039\/c4ob00091a","article-title":"Callyspongisines A\u2013D: Bromopyrrole alkaloids from an Australian marine sponge, callyspongia sp","volume":"12","author":"Plisson","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"B216","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1007\/s12035-018-1249-8","article-title":"Recapitulation of pathological TDP-43 features in immortalized lymphocytes from sporadic ALS patients","volume":"56","author":"Posa","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"B217","doi-asserted-by":"publisher","first-page":"06490937","DOI":"10.1101\/2022.05.06.490937","article-title":"Modulation of tau tubulin kinases (TTBK1 and TTBK2) impacts ciliogenesis","volume":"2022","author":"Potjewyd","year":"2022","journal-title":"bioRxiv"},{"key":"B218","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1046\/j.1432-1327.1999.00195.x","article-title":"Optimal sequences for non-phosphate-directed phosphorylation by protein kinase CK1 (casein kinase-1)--a re-evaluation.","volume":"260","author":"Pulgar","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"B219","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/1098-1004(200007)16:1<95:AID-HUMU28>3.0.CO;2-H","article-title":"A novel presenilin 1 missense mutation (L153V) segregating with early-onset autosomal dominant Alzheimer\u2019s disease","volume":"16","author":"Raux","year":"2000","journal-title":"Hum. Mutat."},{"key":"B220","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1001\/archneur.63.2.262","article-title":"The G93C mutation in superoxide dismutase 1: Clinicopathologic phenotype and prognosis","volume":"63","author":"Regal","year":"2006","journal-title":"Arch. Neurol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B222","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/sj.embor.7400048","article-title":"D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a","volume":"5","author":"Rena","year":"2004","journal-title":"EMBO Rep."},{"key":"B223","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics","volume":"17","author":"Renton","year":"2013","journal-title":"Nat. Neurosci."},{"key":"B224","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1582-4934.2008.00344.x","article-title":"Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease beta-amyloid production","volume":"13","author":"Rezai-Zadeh","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"B225","doi-asserted-by":"publisher","first-page":"7933","DOI":"10.1021\/jm500600b","article-title":"Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1\u03b4 and \u03b5 with nanomolar inhibitory activity on cancer cell proliferation","volume":"57","author":"Richter","year":"2014","journal-title":"J. Med. Chem."},{"key":"B226","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1055\/a-0633-9492","article-title":"A pharmacological update of ellagic acid","volume":"84","author":"R\u00edos","year":"2018","journal-title":"Planta Med."},{"key":"B227","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrn3430","article-title":"The changing scene of amyotrophic lateral sclerosis","volume":"14","author":"Robberecht","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"B228","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12974-015-0470-x","article-title":"Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer\u2019s disease pathology","volume":"13","author":"Rosenberger","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"B229","doi-asserted-by":"publisher","first-page":"191","DOI":"10.31887\/DCNS.2007.9.2\/arosenblatt","article-title":"Neuropsychiatry of Huntington\u2019s disease","volume":"9","author":"Rosenblatt","year":"2007","journal-title":"Dialogues Clin. Neurosci."},{"key":"B231","first-page":"16","article-title":"Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats","volume":"59","author":"Rubinsztein","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"B232","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/hmg\/ddn407","article-title":"Combined kinase inhibition modulates Parkin inactivation","volume":"18","author":"Rubio de la Torre","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"B233","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1021\/jm500065f","article-title":"Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis.","volume":"57","author":"Salado","year":"2014","journal-title":"J. Med. Chem."},{"key":"B234","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.bbamcr.2009.01.013","article-title":"Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis","volume":"1793","author":"Salvi","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"B235","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.cell.2016.05.020","article-title":"Restricted location of PSEN2\/\u03b3-secretase determines substrate specificity and generates an intracellular A\u03b2 pool","volume":"166","author":"Sannerud","year":"2016","journal-title":"Cell"},{"key":"B236","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/s0014-5793(01)02404-8","article-title":"Selectivity of 4, 5, 6, 7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 (\u201ccasein kinase-2\u201d)","volume":"496","author":"Sarno","year":"2001","journal-title":"FEBS Lett."},{"key":"B237","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1046\/j.1471-4159.1999.0722498.x","article-title":"A novel presenilin-2 splice variant in human Alzheimer\u2019s disease brain tissue","volume":"72","author":"Sato","year":"1999","journal-title":"J. Neurochem."},{"key":"B238","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/j.1471-4159.2006.04059.x","article-title":"Tau-tubulin kinase 1 (TTBK1), a neuron-specific tau kinase candidate, is involved in tau phosphorylation and aggregation","volume":"98","author":"Sato","year":"2006","journal-title":"J. Neurochem."},{"key":"B239","doi-asserted-by":"publisher","first-page":"14511","DOI":"10.1523\/jneurosci.3417-08.2008","article-title":"Spatial learning impairment, enhanced CDK5\/p35 activity, and downregulation of NMDA receptor expression in transgenic mice expressing tau-tubulin kinase 1","volume":"28","author":"Sato","year":"2008","journal-title":"J. Neurosci."},{"key":"B240","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/s0197-4580(00)00110-x","article-title":"Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases","volume":"21","author":"Schwab","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"B241","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.bioorg.2011.07.004","article-title":"Protein kinase biochemistry and drug discovery","volume":"39","author":"Schwartz","year":"2011","journal-title":"Bioorg. Chem."},{"key":"B242","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1016\/j.bbagen.2017.09.018","article-title":"Quinalizarin inhibits adipogenesis through down-regulation of transcription factors and microRNA modulation","volume":"1861","author":"Schwind","year":"2017","journal-title":"Biochim. Biophys. Acta. Gen. Subj."},{"key":"B243","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s11064-011-0661-5","article-title":"Protective role of quercetin on PCBs-induced oxidative stress and apoptosis in hippocampus of adult rats","volume":"37","author":"Selvakumar","year":"2012","journal-title":"Neurochem. Res."},{"key":"B244","doi-asserted-by":"publisher","first-page":"802","DOI":"10.4103\/pm.pm_329_21","article-title":"Chrysoeriol promotes functional neurological recovery in a rat model of cerebral ischemia","volume":"17","author":"Shao","year":"2021","journal-title":"Phcog. Mag."},{"key":"B245","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.brainresbull.2007.01.016","article-title":"Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: Implications in neuroprotection","volume":"73","author":"Sharma","year":"2007","journal-title":"Brain Res. Bull."},{"key":"B246","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/77060","article-title":"Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase","volume":"25","author":"Shimura","year":"2000","journal-title":"Nat. Genet."},{"key":"B247","doi-asserted-by":"publisher","first-page":"10288","DOI":"10.1158\/0008-5472.CAN-10-1893","article-title":"CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy.","volume":"70","author":"Siddiqui-Jain","year":"2010","journal-title":"Cancer Res."},{"key":"B248","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.molbrainres.2004.05.019","article-title":"Expression of truncated presenilin 2 splice variant in Alzheimer\u2019s disease, bipolar disorder, and schizophrenia brain cortex","volume":"127","author":"Smith","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"key":"B249","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"B250","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"B251","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1093\/hmg\/ddi292","article-title":"Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin","volume":"14","author":"Sriram","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"B252","doi-asserted-by":"publisher","first-page":"644219","DOI":"10.3389\/fphar.2021.644219","article-title":"Resveratrol in rodent models of Parkinson\u2019s disease: A systematic review of experimental studies","volume":"12","author":"Su","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B253","doi-asserted-by":"publisher","first-page":"E7522","DOI":"10.1073\/pnas.1802422115","article-title":"Tumor promoter TPA activates Wnt\/\u03b2-catenin signaling in a casein kinase 1-dependent manner","volume":"115","author":"Su","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B254","doi-asserted-by":"publisher","first-page":"13743","DOI":"10.1038\/s41598-019-50197-x","article-title":"Inhibition of casein kinase 1\u03b4\/\u03b5 improves cognitive-affective behavior and reduces amyloid load in the APP-PS1 mouse model of Alzheimer\u2019s disease","volume":"9","author":"Sundaram","year":"2019","journal-title":"Sci. Rep."},{"key":"B255","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1006\/bbrc.1995.1354","article-title":"Halogenated benzimidazoles and benzotriazoles as selective inhibitors of protein kinases CK-I and CK-ii from Saccharomyces cerevisiae and other sources","volume":"208","author":"Szyszka","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B256","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.cell.2015.05.028","article-title":"A single kinase generates the majority of the secreted phosphoproteome","volume":"161","author":"Tagliabracci","year":"2015","journal-title":"Cell"},{"key":"B257","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0014-5793(95)00955-9","article-title":"A novel tau-tubulin kinase from bovine brain","volume":"372","author":"Takahashi","year":"1995","journal-title":"FEBS Lett."},{"key":"B258","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1097\/01.wnr.0000133297.77278.81","article-title":"Analysis of the expression, localization and activity of rat casein kinase 1epsilon-3.","volume":"15","author":"Takano","year":"2004","journal-title":"Neuroreport"},{"key":"B259","doi-asserted-by":"publisher","first-page":"7789","DOI":"10.1073\/pnas.90.16.7789","article-title":"Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity","volume":"90","author":"Takashima","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B260","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0002-9440(10)62486-8","article-title":"Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer\u2019s disease","volume":"66","author":"Tanimukai","year":"2005","journal-title":"Am. J. Pathol."},{"key":"B261","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1146\/annurev.biochem.78.070907.103047","article-title":"The chemical biology of protein phosphorylation","volume":"78","author":"Tarrant","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"B262","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1111\/febs.14866","article-title":"Tau tubulin kinases in proteinopathy","volume":"286","author":"Taylor","year":"2019","journal-title":"FEBS J."},{"key":"B263","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13024-018-0237-9","article-title":"Pathological phosphorylation of tau and TDP-43 by TTBK1 and TTBK2 drives neurodegeneration","volume":"13","author":"Taylor","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"B264","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tibs.2010.09.006","article-title":"Protein kinases: Evolution of dynamic regulatory proteins","volume":"36","author":"Taylor","year":"2011","journal-title":"Trends biochem. Sci."},{"key":"B265","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1096\/fasebj.9.13.7557015","article-title":"How do protein kinases discriminate between serine\/threonine and tyrosine? Structural insights from the insulin receptor protein-tyrosine kinase","volume":"9","author":"Taylor","year":"1995","journal-title":"FASEB J."},{"key":"B266","doi-asserted-by":"publisher","first-page":"105548","DOI":"10.1016\/j.nbd.2021.105548","article-title":"Tau-tubulin kinase 1 phosphorylates TDP-43 at disease-relevant sites and exacerbates TDP-43 pathology","volume":"161","author":"Tian","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"B267","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer\u2019s disease: Pathogenesis, diagnostics, and therapeutics","volume":"14","author":"Tiwari","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"B268","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/s0014-5793(01)02256-6","article-title":"Tau-tubulin kinase phosphorylates tau at Ser-208 and Ser-210, sites found in paired helical filament-tau","volume":"492","author":"Tomizawa","year":"2001","journal-title":"FEBS Lett."},{"key":"B269","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1212\/wnl.0000000000002035","article-title":"A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease","volume":"85","author":"Turner","year":"2015","journal-title":"Neurology"},{"key":"B270","doi-asserted-by":"publisher","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","article-title":"Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease","volume":"90","author":"Ueda","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B271","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.3390\/molecules25225243","article-title":"Important flavonoids and their role as a therapeutic agent","volume":"25","author":"Ullah","year":"2020","journal-title":"Molecules"},{"key":"B272","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1471-4159.2007.04764.x","article-title":"Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation","volume":"103","author":"Uversky","year":"2007","journal-title":"J. Neurochem."},{"key":"B273","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.3390\/ijms23063223","article-title":"Oncogenic pathways in neurodegenerative diseases","volume":"23","author":"Varela","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B274","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.1471-4159.2006.03742.x","article-title":"Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTR-dependent motor neuron apoptosis","volume":"97","author":"Vargas","year":"2006","journal-title":"J. Neurochem."},{"key":"B275","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"B276","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1016\/j.neurobiolaging.2009.12.021","article-title":"Genetic variations in tau-tubulin kinase-1 are linked to Alzheimer\u2019s disease in a Spanish case-control cohort","volume":"32","author":"Vazquez-Higuera","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"B277","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1042\/bj20140178","article-title":"Casein kinase: The triple meaning of a misnomer","volume":"460","author":"Venerando","year":"2014","journal-title":"Biochem. J."},{"key":"B278","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/pmic.200600458","article-title":"Proteomic analysis of SET-binding proteins","volume":"7","author":"Vera","year":"2007","journal-title":"Proteomics"},{"key":"B279","doi-asserted-by":"publisher","first-page":"815765","DOI":"10.3389\/fnins.2022.815765","article-title":"Expanding the TDP-43 proteinopathy pathway from neurons to muscle: Physiological and pathophysiological functions","volume":"16","author":"Versluys","year":"2022","journal-title":"Front. Neurosci."},{"key":"B280","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0005-2744(71)90249-x","article-title":"Protein kinase activity from lactating bovine mammary gland","volume":"250","author":"Waddy","year":"1971","journal-title":"Biochim. Biophys. Acta"},{"key":"B281","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1021\/cn500201x","article-title":"Casein kinase 1\u03b4\/\u03b5 inhibitor PF-5006739 attenuates opioid drug-seeking behavior","volume":"5","author":"Wager","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"B282","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0304-3940(97)00891-4","article-title":"NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson\u2019s disease","volume":"239","author":"Wakabayashi","year":"1997","journal-title":"Neurosci. Lett."},{"key":"B283","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/BF03401652","article-title":"The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum","volume":"2","author":"Walter","year":"1996","journal-title":"Mol. Med."},{"key":"B284","doi-asserted-by":"publisher","first-page":"14634","DOI":"10.1074\/jbc.m011116200","article-title":"Phosphorylation regulates intracellular trafficking of \u03b2-secretase","volume":"276","author":"Walter","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B285","doi-asserted-by":"publisher","first-page":"23523","DOI":"10.1074\/jbc.M002850200","article-title":"Phosphorylation of the beta-amyloid precursor protein at the cell surface by ectocasein kinases 1 and 2","volume":"275","author":"Walter","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B286","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1385\/1-59259-195-7:317","article-title":"The phosphorylation of presenilin proteins","volume":"32","author":"Walter","year":"2000","journal-title":"Methods Mol. Med."},{"key":"B287","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1124\/jpet.109.151415","article-title":"Selective inhibition of casein kinase 1 minimally alters circadian clock period","volume":"330","author":"Walton","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B288","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.chembiol.2004.01.015","article-title":"Synthesis and target identification of hymenialdisine analogs","volume":"11","author":"Wan","year":"2004","journal-title":"Chem. Biol."},{"key":"B289","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1055\/s-2006-957407","article-title":"Inhibition of eukaryote serine\/threonine-specific protein kinases by piceatannol","volume":"64","author":"Wang","year":"1998","journal-title":"Planta Med."},{"key":"B290","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3233\/JAD-210735","article-title":"Flavonoids with potential anti-amyloidogenic effects as therapeutic drugs for treating alzheimer's disease","volume":"84","author":"Wang","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"B291","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/molecules21020136","article-title":"The inhibitory mechanisms study of 5, 6, 4\u2032-trihydroxy-7, 3\u2032-dimethoxyflavone against the LPS-induced macrophage inflammatory responses through the antioxidant ability","volume":"21","author":"Wang","year":"2016","journal-title":"Molecules"},{"key":"B292","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/NEN.0b013e31816fc995","article-title":"Specificity and regulation of casein kinase\/mediated phosphorylation of \u03b1-synuclein","volume":"67","author":"Waxman","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B293","doi-asserted-by":"publisher","first-page":"9446","DOI":"10.1111\/jcmm.15616","article-title":"Ellagic acid protects dopamine neurons from rotenone-induced neurotoxicity via activation of Nrf2 signalling","volume":"24","author":"Wei","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"B294","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A protein factor essential for microtubule assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B295","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.chembiol.2020.12.013","article-title":"Development of a potent and selective chemical probe for the pleiotropic kinase CK2","volume":"28","author":"Wells","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"B296","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1006\/geno.1994.1056","article-title":"The human gene (CSNK2A1) coding for the casein kinase II subunit alpha is located on chromosome 20 and contains tandemly arranged Alu repeats","volume":"19","author":"Wirkner","year":"1994","journal-title":"Genomics"},{"key":"B297","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/hmg\/ddg156","article-title":"Huntingtin contains a highly conserved nuclear export signal","volume":"12","author":"Xia","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"B298","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1096\/fj.09-150144","article-title":"Tau-tubulin kinase 1 enhances prefibrillar tau aggregation and motor neuron degeneration in P301L FTDP-17 tau-mutant mice","volume":"24","author":"Xu","year":"2010","journal-title":"FASEB J."},{"key":"B299","doi-asserted-by":"publisher","first-page":"144005","DOI":"10.1016\/j.gene.2019.144005","article-title":"Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D)","volume":"715","author":"Xu","year":"2019","journal-title":"Gene"},{"key":"B300","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/jnc.13234","article-title":"The phosphorylation of \u03b1-synuclein: Development and implication for the mechanism and therapy of the Parkinson's disease.","volume":"135","author":"Xu","year":"2015","journal-title":"J. Neurochem."},{"key":"B301","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1002\/cmdc.201300274","article-title":"X-ray structural analysis of tau-tubulin kinase 1 and its interactions with small molecular inhibitors","volume":"8","author":"Xue","year":"2013","journal-title":"ChemMedChem"},{"key":"B302","doi-asserted-by":"publisher","first-page":"e0224952","DOI":"10.1371\/journal.pone.0224952","article-title":"Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization","volume":"15","author":"Yadikar","year":"2020","journal-title":"PLOS ONE"},{"key":"B303","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1074\/jbc.M407724200","article-title":"Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity","volume":"280","author":"Yamamoto","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B304","doi-asserted-by":"publisher","first-page":"4628","DOI":"10.3390\/ijms22094628","article-title":"Resveratrol, metabolic dysregulation, and Alzheimer\u2019s disease: Considerations for neurogenerative disease","volume":"22","author":"Yang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B305","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cellsig.2016.12.010","article-title":"Molecular basis for the regulation of the circadian clock kinases CK1\u03b4 and CK1\u03b5","volume":"31","author":"Yang","year":"2017","journal-title":"Cell. Signal."},{"key":"B306","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1006\/geno.1994.1032","article-title":"Assignment of the human casein kinase II alpha' subunit gene (CSNK2A1) to chromosome 16p13.2-p13.3.","volume":"19","author":"Yang-Feng","year":"1994","journal-title":"Genomics"},{"key":"B307","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/s0006-8993(00)02970-x","article-title":"Human neurons generate C-reactive protein and amyloid P: Upregulation in Alzheimer\u2019s disease","volume":"887","author":"Yasojima","year":"2000","journal-title":"Brain Res."},{"key":"B308","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.canlet.2007.06.010","article-title":"Induction of cell death in antiestrogen resistant human breast cancer cells by the protein kinase CK2 inhibitor DMAT","volume":"256","author":"Yde","year":"2007","journal-title":"Cancer Lett."},{"key":"B309","doi-asserted-by":"publisher","first-page":"7940","DOI":"10.1074\/jbc.M807482200","article-title":"Conversion of wildtype alpha-synuclein into mutant-type fibrils and its propagation in the presence of A30P mutant","volume":"284","author":"Yonetani","year":"2009","journal-title":"J. Biol. Chem."},{"key":"B310","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/j.1471-4159.1993.tb03642.x","article-title":"Tau in paired helical filaments is functionally distinct from fetal tau: Assembly incompetence of paired helical filament-tau.","volume":"61","author":"Yoshida","year":"1993","journal-title":"J. Neurochem."},{"key":"B311","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.neurobiolaging.2012.12.025","article-title":"Ser9 phosphorylation causes cytoplasmic detention of I2PP2A\/SET in Alzheimer disease","volume":"34","author":"Yu","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"B312","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neulet.2011.01.011","article-title":"Tau-tubulin kinase-1 gene variants are associated with Alzheimer\u2019s disease in Han Chinese","volume":"491","author":"Yu","year":"2011","journal-title":"Neurosci. Lett."},{"key":"B313","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s12035-015-9639-7","article-title":"Resveratrol pretreatment decreases ischemic injury and improves neurological function via sonic hedgehog signaling after stroke in rats","volume":"54","author":"Yu","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"B314","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.lfs.2019.03.055","article-title":"Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer\u2019s disease","volume":"224","author":"Zaplatic","year":"2019","journal-title":"Life Sci."},{"key":"B315","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1016\/j.tetlet.2012.05.051","article-title":"A search for kinase inhibitors and antibacterial agents: Bromopyrrolo-2-aminoimidazoles from a deep-water Great Australian Bight sponge Axinella sp","volume":"53","author":"Zhang","year":"2012","journal-title":"Tetrahedron Lett."},{"key":"B316","doi-asserted-by":"publisher","first-page":"16319","DOI":"10.1021\/bi9614444","article-title":"Casein kinase I \u03b1 and \u03b1L: Alternative splicing-generated kinases exhibit different catalytic properties","volume":"35","author":"Zhang","year":"1996","journal-title":"Biochemistry"},{"key":"B317","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1523\/JNEUROSCI.4248-14.2015","article-title":"Phosphorylation of synaptic vesicle protein 2A at Thr84 by casein kinase 1 family kinases controls the specific retrieval of synaptotagmin-1","volume":"35","author":"Zhang","year":"2015","journal-title":"J. Neurosci."},{"key":"B318","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3389\/fnmol.2018.00146","article-title":"CK2 phosphorylating I2PP2A\/SET mediates tau pathology and cognitive impairment","volume":"11","author":"Zhang","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"B319","doi-asserted-by":"publisher","first-page":"7607","DOI":"10.1073\/pnas.0900688106","article-title":"Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B320","doi-asserted-by":"publisher","first-page":"136151","DOI":"10.1016\/j.neulet.2021.136151","article-title":"Resveratrol inhibits inflammation after spinal cord injury via SIRT-1\/NF-\u03baB signaling pathway","volume":"762","author":"Zhao","year":"2021","journal-title":"Neurosci. Lett."},{"key":"B322","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1101\/gad.319830.118","article-title":"Regulation of MLL\/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia","volume":"33","author":"Zhao","year":"2018","journal-title":"Genes Dev."},{"key":"B323","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1750-1326-1-5","article-title":"The amyloid precursor protein: Beyond amyloid","volume":"1","author":"Zheng","year":"2006","journal-title":"Mol. Neurodegener."},{"key":"B324","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-021-00276-9","article-title":"Translational Neurodegeneration in the era of fast growing international brain research","volume":"11","author":"Zheng","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"B325","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.4103\/0019-509X.172508","article-title":"Quinalizarin, a specific CK2 inhibitor, reduces cell viability and suppresses migration and accelerates apoptosis in different human lung cancer cell lines","volume":"52","author":"Zhou","year":"2015","journal-title":"Indian J. Cancer"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.916063\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T13:18:32Z","timestamp":1665062312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.916063\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":321,"alternative-id":["10.3389\/fmolb.2022.916063"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2022.916063","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,6]]},"article-number":"916063"}}